Drugs by condition
Drugs approved for osteoarthritis
Last checked: Nov 20, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations
Brand-name drugs approved
18
Still marketed, NDA or BLA
Drug classes
4
Novel drugs
3
New molecular entities and new biologics
In development
34
Investigational drugs in Phase 2 or 3
Newest approvals
The most recently first-approved brand-name drugs for osteoarthritis.
- Vyscoxa (Celecoxib) · Carwin Pharm Assoc Jul 29, 2025
- Coxanto (Oxaprozin) · Solubiomix Oct 20, 2023
- Zilretta (Triamcinolone Acetonide) · Pacira Pharms INC Oct 6, 2017
- Voltaren Arthritis Pain (Diclofenac Sodium) · Haleon US Holdings Oct 17, 2007
- Meloxicam (Meloxicam) · Avondale Pharms OrphanJun 1, 2004
All approved drugs for osteoarthritis, by class
Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 265 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.
Nonsteroidal Anti-inflammatory Drug (8)
- Celebrex Celecoxib · Upjohn · 1998
- Vyscoxa Celecoxib · Carwin Pharm Assoc · 2025
- Coxanto Oxaprozin · Solubiomix · 2023
- Meloxicam Meloxicam · Avondale Pharms · 2004
- Ec-Naprosyn Naproxen · Atnahs Pharma US · 1994
- Naprosyn Naproxen · Atnahs Pharma US · 1987
- Indocin Indomethacin · Cosette · 1985
- Indomethacin Indomethacin · Chartwell Molecules · 1984
Corticosteroid (4)
- Medrol Methylprednisolone · Pfizer · 1957
- Kenalog-40 Triamcinolone Acetonide · Apothecon · 1965
- Kenalog-10 Triamcinolone Acetonide · Apothecon · 1960
- Cortef Hydrocortisone · Pharmacia and Upjohn · 1952
Prostaglandin E1 Analog (1)
- Arthrotec Diclofenac Sodium, Misoprostol · Pfizer · 1997
Class not listed in FDA's data (5)
- Celestone Soluspan Betamethasone Acetate, Betamethasone Sodium Phosphate · Organon · 1965
- Zilretta Triamcinolone Acetonide · Pacira Pharms INC · 2017
- Voltaren Arthritis Pain Diclofenac Sodium · Haleon US Holdings · 2007
- Naprelan Naproxen Sodium · Twi Pharms · 1996
- Depo-Medrol Methylprednisolone Acetate · Pfizer · 1959
Drugs in development for osteoarthritis
Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.
- EloralintideLY3841136Phase 313 trials
Eli Lilly · Obesity, Overweight, Diabetes Mellitus, Type 2
- NNC0487-0111Phase 312 trials
Novo Nordisk · Obesity, Overweight, Obstructive Sleep Apnoea
- matched to NNC0487-0111Phase 39 trials
Novo Nordisk · Obesity, Overweight, Obstructive Sleep Apnoea
- EcnoglutideXW003, VRB-101Phase 38 trials
Hangzhou Sciwind Biosciences Co., Ltd. · Obesity, Weight Management, OSA - Obstructive Sleep Apnea
- hUC-MSCsmesenchymal stem cells, MSCPhase 38 trials
Shenzhen Wingor Biotechnology Co., Ltd. · Knee Osteoarthritis, Crohn&Amp;#39;s, Crohn&Amp;#39;s Disease (CD)
- RibupatideKAI-9531Phase 35 trials
Kailera · Obesity, Overweight, Obesity With Diabetes
- EtoricoxibPhase 34 trials
Laboratorios Silanes S.A. de C.V. · Gout Arthritis, Gout Attack, Acute Low-back Pain
- JOINTSTEMPhase 32 trials
R-Bio · Knee Osteoarthritis, Osteoarthritis, Knee
- Reference DrugNSAIDsPhase 32 trials
SANGMYUNG innovation · Retinal Vein Occlusion With Macular Edema, Knee Osteoarthritis
- RTX-GRT7039Phase 32 trials
Grünenthal GmbH · Osteoarthritis
- TG-CTissueGene-CPhase 32 trials
Kolon TissueGene, Inc. · Degenerative Osteoarthritis
- CLS2901Chuman [allogeneic] chondrocyte sheetsPhase 31 trial
CellSeed Inc. · Osteoarthritis of the Knee
- PTP-01MOTYS, allogeneic human placental tissue particulatePhase 31 trial
Doron Therapeutics Inc. · Knee Osteoarthritis
- SL1002Phase 31 trial
Saol Therapeutics Inc · Osteoarthritis Knee Pain
- [StroMedPhase 23 trials
VivaTech International, Inc. · Osteoarthritis
- LY4065967Phase 23 trials
Eli Lilly · Chronic Pain, Diabetic Peripheral Neuropathic Pain, Osteoarthritis, Knee
- mesenchymal stem cellumbilical cord derived MSCsPhase 23 trials
Cell Energy Life Sciences Group Co. LTD · AIDS, Ischemic Heart Disease, Osteoarthritis
- AllocetraPhase 22 trials
Enlivex Therapeutics Ltd. · Primary Knee Osteoarthritis, Osteoarthritis, Knee
- DFV890Phase 22 trials
Novartis · Coronary Heart Disease, Symptomatic Knee Osteoarthritis
- Human umbilical cord blood-derived mesenchymal stem cellsSMUP-IA-01, mid-dosePhase 22 trials
Medipost Co Ltd. · Knee Osteoarthritis, Bronchopulmonary Dysplasia, BPD
More on osteoarthritis: recruiting trials · published research
Related in pain and anesthesia: Neuropathic pain · Acute pain
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.